Found: 10
Select item for more details and to access through your institution.
Correction to: Targeting and Therapeutic Monitoring of H3K27M-Mutant Glioma.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
There Must Be a Way Out of Here: Identifying a Safe and Efficient Combination of Promoter, Transgene, and Vector Backbone for Gene Therapy of Neurological Disease.
- Published in:
- Molecular Therapy, 2014, v. 22, n. 2, p. 246, doi. 10.1038/mt.2013.297
- By:
- Publication type:
- Article
HGG-08. ATRX LOSS IN PEDIATRIC GBM RESULTS IN EPIGENETIC DYSREGULATION OF G2/M CHECKPOINT MAINTENANCE AND SENSITIVITY TO ATM INHIBITION.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii88, doi. 10.1093/neuonc/noz036.102
- By:
- Publication type:
- Article
HGG-03. EVEROLIMUS TREATMENT IMPROVES THE CNS PENETRATION AND EFFICACY OF DASATINIB IN THE TREATMENT OF PDGFRA-DRIVEN PEDIATRIC HIGH-GRADE GLIOMA AND DIFFUSE INTRINSIC PONTINE GLIOMA.
- Published in:
- Neuro-Oncology, 2019, v. 21, p. ii87, doi. 10.1093/neuonc/noz036.097
- By:
- Publication type:
- Article
CSIG-08. DYNAMICS OF GLIOMA GROWTH: SELF-ORGANIZATION GUIDES THE PATTERNING OF THE EXTRACELLULAR MATRIX AND REGULATES TUMOR PROGRESSION.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi44, doi. 10.1093/neuonc/noy148.174
- By:
- Publication type:
- Article
Molecular ablation of tumor blood vessels inhibits therapeutic effects of radiation and bevacizumab.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 10, p. 1356, doi. 10.1093/neuonc/noy055
- By:
- Publication type:
- Article
Everolimus improves the efficacy of dasatinib in PDGFRα-driven glioma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Receptor tyrosine kinase (RTK) targeting in pediatric high-grade glioma and diffuse midline glioma: Pre-clinical models and precision medicine.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.922928
- By:
- Publication type:
- Article
Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 8, p. 1366, doi. 10.1093/neuonc/noac030
- By:
- Publication type:
- Article
Therapeutic targeting of differentiation-state dependent metabolic vulnerabilities in diffuse midline glioma.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-52973-4
- By:
- Publication type:
- Article